News

They arrange themselves facing Bob, who sits at center stage, and do not take their eyes off him for one minute. On the drums currently is Anton Fig, who most people know from his tenure on "The ...
Co-CEO Bob Duggan highlighted significant progress with ivonescimab, Summit Therapeutics' lead investigational asset, emphasizing its potential impact on unmet medical needs. Key milestones ...
Cantor Fitzgerald views Bob Duggan’s, Summit Therapeutics (SMMT) co-CEO and Chairman, stock option exercise “quite unusual” and “quite bullish” for the shares. Duggan’ exercised ...
Disney’s chief executive Bob Iger built his reputation on doing ... there are more than ten people with Disney affinity who do not visit the parks.” However, the colossal construction costs ...
On Thursday, Cantor Fitzgerald reaffirmed its Overweight rating on Summit Therapeutics plc (NASDAQ:SMMT), following a noteworthy move by the company's co-CEO and Chairman Bob Duggan. Duggan ...
Bob Duggan, indicated a bullish signal for the stock. According to a regulatory filing on Wednesday, Duggan, a venture capitalist who already owns 556M shares of the company (70% of ownership ...
The 151st Kentucky Derby is just eight days away. Famed trainer Bob Baffert, in his return to the Kentucky Derby after a three-year suspension, had three horses on the Derby leaderboard.
but I’m going to do it because I’m trying to help the people of Michigan,’ and she gets beat up for it,” Duggan said. “Now Trump is a master stage master and he did embarrass her.
Summit’s CEO, Bob Duggan, is now among the richest executives in biotech as a result. Akeso has two other leading assets: ebdarokimab, a treatment for autoimmune diseases, and anti-PCSK9 ...
On Thursday, Cantor Fitzgerald maintained its Overweight rating on SMMT following a move by the company’s co-CEO and chairman Bob Duggan to exercise warrants to acquire 4 million SMMT shares.